当前位置: X-MOL 学术Eur. J. Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19.
European Journal of Neurology ( IF 5.1 ) Pub Date : 2020-09-09 , DOI: 10.1111/ene.14511
M Cappellari 1 , A Zini 2 , D Sangalli 3 , A Cavallini 4 , M Reggiani 5 , F N Sepe 6 , N Rifino 7 , G Giussani 8 , D Guidetti 9 , M Zedde 10 , S Marcheselli 11 , M Longoni 12 , S Beretta 13 , V Sidoti 14 , D M Papurello 15 , A Giossi 16 , P Nencini 17 , M Plocco 18 , M Balestrino 19 , E Rota 20 , D Toni 21
Affiliation  

Comorbidity of acute ischaemic stroke with Covid‐19 is a challenging condition, potentially influencing the decision of whether to administer intravenous thrombolysis (IVT). We aimed to assess the 1‐month outcome in ischaemic stroke patients with Covid‐19 infection who received IVT alone or before thrombectomy (bridging therapy).

中文翻译:

急性缺血性卒中和Covid-19患者的溶栓和桥接治疗。

Covid‐19合并急性缺血性中风是一种具有挑战性的疾病,可能会影响是否进行静脉溶栓治疗(IVT)的决定。我们旨在评估仅接受IVT或在血栓切除术(桥接治疗)之前接受IVT的缺血性卒中合并Covid-19感染的中风患者的1个月预后。
更新日期:2020-11-09
down
wechat
bug